Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Nutrients utilization in obese individuals with and without hypertriglyceridemia.

Montalcini T, Lamprinoudi T, Morrone A, Mazza E, Gazzaruso C, Romeo S, Pujia A.

Nutrients. 2014 Feb 21;6(2):790-8. doi: 10.3390/nu6020790.

2.

Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects.

Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, Hirsch J.

J Lipid Res. 2000 Apr;41(4):595-604.

3.

Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals.

Pujia A, Gazzaruso C, Ferro Y, Mazza E, Maurotti S, Russo C, Lazzaro V, Romeo S, Montalcini T.

Nutrients. 2016 Jan 4;8(1). pii: E2. doi: 10.3390/nu8010002.

4.

Fat utilization and arterial hypertension in overweight/obese subjects.

Ferro Y, Gazzaruso C, Coppola A, Romeo S, Migliaccio V, Giustina A, Pujia A, Montalcini T.

J Transl Med. 2013 Jul 2;11:159. doi: 10.1186/1479-5876-11-159.

5.

Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients.

Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G.

Diabetes Metab. 2001 Feb;27(1):31-5.

PMID:
11240443
6.

Subclinical cardiovascular damage and fat utilization in overweight/obese individuals receiving the same dietary and pharmacological interventions.

Montalcini T, Lamprinoudi T, Gorgone G, Ferro Y, Romeo S, Pujia A.

Nutrients. 2014 Dec 1;6(12):5560-71. doi: 10.3390/nu6125560.

7.

Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia.

Koh KK, Quon MJ, Shin KC, Lim S, Lee Y, Sakuma I, Lee K, Han SH, Shin EK.

Atherosclerosis. 2012 Feb;220(2):537-44. doi: 10.1016/j.atherosclerosis.2011.11.018. Epub 2011 Nov 19.

PMID:
22153696
8.

[The hypotriglyceridemic effects of polyunsaturated fatty acids: pathogenetic hypothesis].

Del Ponte A, Bitti G, Di Giacomo G, Marinari S.

Riv Eur Sci Med Farmacol. 1995 Sep-Oct;17(5):175-82. Italian.

PMID:
8766785
9.

Hormonal and dietary characteristics in obese human subjects with and without food addiction.

Pedram P, Sun G.

Nutrients. 2014 Dec 31;7(1):223-38. doi: 10.3390/nu7010223.

10.

High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.

Clifton PM, Bastiaans K, Keogh JB.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):548-54. doi: 10.1016/j.numecd.2008.10.006. Epub 2009 Jan 29.

PMID:
19179060
11.

Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients.

Waldmann E, Hüttl TP, Göke B, Lang R, Parhofer KG.

Lipids Health Dis. 2013 Jun 1;12:82. doi: 10.1186/1476-511X-12-82.

12.

Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease.

Kumar V, Madhu SV, Singh G, Gambhir JK.

J Assoc Physicians India. 2010 Oct;58:603-7.

PMID:
21510110
13.

Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.

Salgado-Montilla J, Soto Salgado M, Surillo Trautmann B, Sánchez-Ortiz R, Irizarry-Ramírez M.

Lipids Health Dis. 2015 Sep 17;14:111. doi: 10.1186/s12944-015-0096-0.

14.

Metabolic risk factors associated with erosive esophagitis.

Chua CS, Lin YM, Yu FC, Hsu YH, Chen JH, Yang KC, Shih CH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1375-9. doi: 10.1111/j.1440-1746.2009.05858.x. Epub 2009 May 10.

PMID:
19467140
15.

Prevalence and determinants of hyperlipidemia in moderate altitude areas of the Yunnan-Kweichow plateau in Southwestern China.

Deng B, Luo T, Huang Y, Shen T, Ma J.

High Alt Med Biol. 2012 Mar;13(1):13-21. doi: 10.1089/ham.2011.1037.

16.

Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects.

Herranz L, Zapata A, Grande C, Megia A, Pallardo LF.

Horm Metab Res. 1998 Mar;30(3):141-5.

PMID:
9566856
17.

Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.

Li Z, Deng ML, Tseng CH, Heber D.

Metab Syndr Relat Disord. 2013 Apr;11(2):87-91. doi: 10.1089/met.2012.0090. Epub 2012 Dec 21.

PMID:
23259588
18.

Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.

Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M.

Metabolism. 2008 Nov;57(11):1597-607. doi: 10.1016/j.metabol.2008.06.017.

PMID:
18940400
19.

Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?

Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.

Gynecol Endocrinol. 2016;32(1):38-41. doi: 10.3109/09513590.2015.1075501. Epub 2015 Aug 18.

PMID:
26291816
20.

Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects.

Guerrero-Romero F, Rodriguez-Moran M.

Eur J Intern Med. 2013 Oct;24(7):639-43. doi: 10.1016/j.ejim.2013.02.014. Epub 2013 Mar 20.

PMID:
23523313

Supplemental Content

Support Center